Back to top

Image: Bigstock

Fate Therapeutics (FATE) Surges: Stock Moves 6.8% Higher

Read MoreHide Full Article

Fate Therapeutics, Inc. (FATE - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $16.32 to $19.55 in the past one-month time frame.

The company has seen five negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Fate Therapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Fate Therapeutics, Inc. Price

Investors interested in the Medical - Biomedical and Genetics industry may consider Acorda Therapeutics, Inc. , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is FATE going up? Or down? Predict to see what others think:Up or Down

Will you retire a millionaire?

One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”

Click to get it free >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Fate Therapeutics, Inc. (FATE) - free report >>

Published in